Zinc monoterpenoid tetra-ascorbo-camphorate - MGB Pharma
Alternative Names: C-14-MGB-PharmaLatest Information Update: 02 Jan 2025
Price :
$50 *
At a glance
- Originator MGB Pharma
- Class Antivirals; Monoterpenes; Zinc compounds
- Mechanism of Action Virus attachment modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Human papillomavirus infections
Most Recent Events
- 04 Nov 2024 Preclinical trials in Human papillomavirus infections in France (Vaginal)
- 04 Nov 2024 MGB Pharma plans a phase I/II PREPAP trial for Human papillomavirus infections in Congo (Vaiginal) (NCT06672653)